TobaccoReporter logo

Tag: TPA

  • TPA Brief Criticizes WHO Tobacco Treaty for Ignoring Evidence

    TPA Brief Criticizes WHO Tobacco Treaty for Ignoring Evidence

    The Taxpayers Protection Alliance (TPA) released a new policy brief today (October 20), “FCTC: The Wrong Lessons Learned,” by Roger Bate, a fellow at the International Center for Law and Economics, criticizing the World Health Organization’s Framework Convention on Tobacco Control (FCTC) for drifting from its original mission of evidence-based policy. The paper argues that the treaty’s decision-making process has become obscured, ideological, and resistant to scientific debate—particularly around harm reduction products such as e-cigarettes and oral nicotine.

    “The FCTC has evolved into a closed process—hostile to scientific dissent, opaque in its deliberations, and resistant to consumer-driven innovation in tobacco harm reduction (THR),” the paper begins. “This paper argues that the FCTC has become a cautionary model for global public-health governance. Unless checked, this model risks entrenching an authoritarian and anti-scientific impulse across public health. The THR community must lead the counter-narrative—to reform tobacco control and safeguard the integrity of evidence-based policymaking.”

    Bate contends that the FCTC’s approach “demonizes safer alternatives despite real-world success,” preventing adult smokers from accessing less harmful products that could help them quit. He warns that the treaty’s governance flaws mirror broader problems in global health governance, including pandemic response. “A treaty built to reduce smoking deaths should evaluate tools by outcomes, not ideology,” he said.

    The brief calls for reforms, including open sessions at FCTC Conferences of the Parties (COPs), equal conflict-of-interest scrutiny, independent comparisons of cessation tools, proportionate youth protections, and fiscal accountability. TPA fellow Martin Cullip urged the WHO to “reassess the evidence on reduced-risk nicotine products” and improve transparency, warning that the FCTC’s current direction “has become an obstacle to global public health progress.”

  • FCTC Deserves Criticism, Not Celebration, Says TPA

    FCTC Deserves Criticism, Not Celebration, Says TPA

    As the World Health Organization (WHO) marks the 20th anniversary of its Framework Convention on Tobacco Control (FCTC), a panel hosted by the Taxpayers Protection Alliance (TPA) used the occasion to reflect on what they called decades of stagnation, missed opportunities, and dangerous resistance to innovation in the field of tobacco harm reduction.

    “The FCTC should have marked a turning point in global tobacco control,” said Clive Bates, former director of Action on Smoking and Health (UK). “Instead, the WHO remains entrenched in outdated, prohibition-style thinking. They actively oppose safer alternatives like vaping, heated tobacco products, and nicotine pouches—tools that are demonstrably helping people quit smoking.”

    Panelists argued that the WHO’s refusal to embrace harm-reduction approaches is not just short-sighted but scientifically indefensible. Many urged countries participating in the treaty to reconsider their blind alignment with WHO policy and instead focus on pragmatic, evidence-based strategies that prioritize public health outcomes.

    “Whether it’s COVID-19 or tobacco policy, the WHO has failed repeatedly,” Roger Bate, a global health policy expert at the International Center for Law and Economics said. “We need fundamental reform. If the organization cannot evolve to incorporate modern science and real-world solutions, then it risks becoming obsolete.”

    David Williams, president of TPA, echoed this sentiment, calling the WHO’s current approach “dangerous and irresponsible.” He cited the organization’s refusal to recognize smoke-free alternatives, even as mounting research shows their effectiveness in reducing harm. “E-cigarettes and nicotine pouches are saving lives,” Williams said. “These are tools funded by taxpayers, yet the WHO continues to reject them without sound justification. That’s not just bad policy—it’s negligence.”

    Williams also promoted TPA’s global campaign, Good COP/Bad COP, which launched during the 2024 FCTC COP10 meeting in Panama. A follow-up event is planned for 2025 in Geneva, aimed at holding the WHO accountable. “We’re building a coalition of doctors, consumers, and advocates who want the WHO to work for the people, not against them,” he said.

    Martin Cullip, international fellow at TPA’s Consumer Center, summed up the panel’s frustration. “The FCTC was a good idea that has gone terribly wrong. We’ve lost 20 years of potential progress because of rigid ideology.”

    The panel urged WHO leaders to abandon a dogmatic stance and embrace harm reduction as a key component of tobacco control moving forward. As Clive Bates concluded, “The WHO has become unethical, unaccountable, and ineffective. If they truly care about saving lives, they must stop ignoring the science. Harm reduction has to be part of the solution.”